inhibit, GSK2110183, GSK-2110183, GSK 2110183, Inhibitor, Akt, Afuresertib, Afuresertib Hydrochloride, Afuresertib hydrochloride, Protein kinase C, Protein kinase B, Rho-kinase, Rho-associated kinase, Rho-associated protein kinase, ROK, ROCK, PKB, PKC
Afuresertib hydrochloride is a potent and selective pan-Akt kinase inhibitor, exhibiting Kis of 0.08, 2, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. It is widely used in preclinical research to investigate the PI3K/Akt signaling pathway in cancer, with applications in both in vitro cellular assays and in vivo xenograft models.